	Le Bénéfice D'Exploitation		Date
Acadia Pharmaceuticals	USD 35.76M	3.38M	2025-09
Akebia Therapeutics	USD 13.51M	27.82M	2025-03
ALKERMES	USD 89.08M	3.9M	2025-09
Alnylam Pharmaceuticals	USD 29.4M	59.36M	2025-12
Amarin	USD -1.7M	8.47M	2025-09
ANI Pharmaceuticals	USD 22.83M	7.66M	2025-09
BioMarin Pharmaceutical	USD -31.69M	308.58M	2025-09
Coherus Biosciences	USD -45.43M	3.13M	2025-03
Emergent BioSolutions	USD -218M	69.9M	2023-06
Exact Sciences	USD -25M	22.85M	2025-09
Exelixis	USD 235.91M	20.45M	2025-12
Glaxosmithkline	GBP 3.76B	1.32B	2025-09
Heron Therapeutics	USD -5.66M	782K	2024-09
Ionis Pharmaceuticals	USD -160.18M	300.02M	2025-09
Ironwood Pharmaceuticals	USD 33.22M	7.58M	2024-12
Lexicon Pharmaceuticals	USD -55.35M	10.02M	2024-06
Lonza	CHF 430M	104M	2024-12
Merck	USD 6.24B	318M	2025-12
Moderna	USD -857M	597M	2025-12
Myriad Genetics	USD -23.3M	10.8M	2025-09
Nektar Therapeutics	USD -34.34M	15.43M	2024-09
Neurocrine Biosciences	USD 227.9M	11.4M	2025-12
Pacira	USD 13.15M	2.92M	2025-09
Pfizer	USD 4.65B	3.99B	2025-12
PTC Therapeutics	USD 3.49M	38.35M	2025-09
Sanofi	EUR 1.7B	2.17B	2025-12
Sarepta Therapeutics	USD -62.88M	178.46M	2025-09
United Therapeutics	USD 389.3M	112.4M	2025-09
Vanda Pharmaceuticals	USD -40.66M	29.66M	2024-12
Xoma	USD -15.64M	5.56M	2024-09

Emergent BioSolutions Le Bénéfice D'Exploitation - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Feb 2026.